U.S. drug regulators on April 6 said they’re withdrawing the approval of a drug aimed at reducing preterm birth in pregnant women. The U.S. Food and Drug Administration (FDA) is withdrawing approval for Makena, which the same agency approved in 2011. The decision stems from the conclusion that there’s no evidence Makena actually reduces the…